[Evaluation of cardiovascular risk in HIV positive patients in a specialized center at Santiago, Chile]

Rev Chilena Infectol. 2016 Jun;33(3):352-4. doi: 10.4067/S0716-10182016000300018.
[Article in Spanish]


Antiretroviral therapy has changed the course of HIV epidemic, as consequence, the patients present the same medical conditions than the rest ofthe population, including cardiovascular diseases.

Aim: To describe the evolution of cardiovascular risk of HIV positive patients attending to a HIV/AIDS integral clinical center. Clinical charts were reviewed, looking for cardiovascular risk markers. Our findings showed a deficient evaluation of the cardiovascular basal risks at first medical control and patients had important metabolic alterations despite hypolipidemic treatment. Given the higher cardiovascular risk of this population, increasing the effort on diagnosis and treatment of HIV patients is required.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / metabolism*
  • Chile
  • Cholesterol / blood
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Medical Records
  • Retrospective Studies
  • Risk Factors
  • Triglycerides / blood


  • Anti-Retroviral Agents
  • Hypolipidemic Agents
  • Triglycerides
  • Cholesterol